[Corrigendum] Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression
Oncology Reports · 20.05.2026 · 56 (1) · 1-2
DOI: 10.3892/or.2026.9139 ↗Kurz gefasst
Korrektur in der Zeitschrift Oncology Reports, online erschienen am 20.05.2026. Verfasst von Lei Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, concerning the western blots shown in Fig. 1 on p. 457, the p73 data shown for the ZR75‑1 and MCF‑7 cell lines in Fig. 1A and B respectively were very similar if the latter blot were to be flipped vertically. The authors were able to re‑examine their original data, and realized that the p73 data for the ZR75‑1 cell line in Fig. 1A had inadvertently been copied across to show the results for the MCF‑7 cell line experiments in Fig. 1B. The revised version of Fig. 1, now showing the correct data for the p73 blot in Fig. 1B, is shown on the next page. Note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 41: 455‑464, 2019; DOI: 10.3892/or.2018.6842].
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
- Department of Critical Care Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
- Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Zitieren
APA
Zhu, L., Li, X. X., Shi, L., Wu, J., Qian, J. Y., Xia, T. S., Zhou, W. B., Sun, X., Zhou, X. J., Wei, J. F., & Ding, Q. (2026). [Corrigendum] Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression. Oncology Reports, 56(1), 1-2. https://doi.org/10.3892/or.2026.9139
Vancouver
Zhu L, Li XX, Shi L, Wu J, Qian JY, Xia TS, et al. [Corrigendum] Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression. Oncology Reports. 2026;56(1):1-2. doi:10.3892/or.2026.9139
BibTeX
@article{Zhu2026,
author = {Zhu, Lei and Li, Xiao-Xia and Shi, Liang and Wu, Jing and Qian, Jia-Yi and Xia, Tian-Song and Zhou, Wen-Bin and Sun, Xi and Zhou, Xu-Jie and Wei, Ji-Fu and Ding, Qiang},
title = {[Corrigendum] Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression},
journal = {Oncology Reports},
year = {2026},
volume = {56},
number = {1},
pages = {1--2},
doi = {10.3892/or.2026.9139}
}
EUVIMED